All News #Library
Biotech
Avidity Ph1/2 Data Shows Del-Brax Improved FSHD Outcomes
09 Jun 2025 //
PR NEWSWIRE
Fortress Biotech Doses First Patient In Phase 2 Triplex Trial
27 Jan 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support